Skip to main content

Table 1 Clinical parameters of Hct, PF-4, β-TG, FDP, d-dimer, and change ratio of FIB

From: Biocompatibility and small protein permeability of hydrophilic-coated membrane dialyzer (NV) in hemodialysis patients: a pilot study

  

0 (min)

30 (min)

60 (min)

240 (min)

Hct (%)

NV

32.2 ± 2.4

31.4 ± 2.7

32.1 ± 2.6

34.9 ± 3.3

APS

32.0 ± 2.4

30.9 ± 2.3

31.5 ± 2.3

34.4 ± 2.8

PF-4 (ng/mL)

NV

7.45 ± 7.09

29.2 ± 13.5

16.9 ± 8.1

12.3 ± 7.4

APS

6.77 ± 3.69

32.3 ± 21.5

17.3 ± 6.9

12.1 ± 5.8

β-TG (ng/mL)

NV

146 ± 41

128 ± 42

118 ± 36

104 ± 39

APS

135 ± 33

125 ± 40

119 ± 36

101 ± 30

FDP (μg/mL)

NV

2.0(2.0, 2.0)

2.0(2.0, 2.0)

2.0(2.0, 2.0)

2.0(2.0, 3.0)

APS

2.0(2.0, 2.0)

2.0(2.0, 2.0)

2.0(2.0, 3.0)

2.0(2.0, 2.0)

d-dimer (μg/mL)

NV

0.4(0.2, 0.5)

0.3(0.2, 0.5)

0.3(0.2, 0.5)

0.4(0.2, 0.5)

APS

0.4(0.4, 0.5)

0.3(0.2, 0.5)

0.3(0.2, 0.5)

0.3(0.2, 0.5)

Change ratio of FIB (%)

NV

98.6 ± 2.8

102 ± 3

117 ± 8

APS

97.8 ± 3.3

101 ± 4

116 ± 11

  1. FDP and d-dimer are expressed as medians with 25th–75th percentiles
  2. Hct hematocrit, PF-4 platelet factor-4, β-TG thromboglobulin, FDP fibrinogen/fibrin degradation products, FIB fibrinogen